Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through the suppression of p38 and c-Jun N-terminal kinase signaling

Molecular Medicine Reports
Huiyu YangZhiming Yang

Abstract

Angiotensin II (Ang II) and Ang-(1-7) are key effector peptides of the renin-angiotensin system. The present study aimed to investigate the effects of Ang-(1-7) on Ang II-stimulated cholesterol efflux and the associated molecular mechanisms. Differentiated THP-1 macrophages were treated with Ang II (1 µM) and/or Ang-(1-7) (10 and 100 nM) for 24 h and the cholesterol efflux and gene expression levels were assessed. Pharmacological inhibition of peroxisome proliferator-activated receptor (PPAR)γ and mitogen-activated protein kinases (MAPKs) were performed to identify the signaling pathways involved. The results demonstrated that Ang II significantly inhibited the cholesterol efflux from cholesterol-loaded THP-1 macrophages. Treatment with Ang-(1-7) led to a dose-dependent restoration of cholesterol efflux in the Ang II-treated cells. The co-treatment with Ang-(1-7) and Ang II significantly increased the expression levels of adenosine triphosphate (ATP)-binding cassette (ABC)A1 and ABCG1 compared with treatment with Ang II alone. This was coupled with increased expression levels of PPARγ and liver X receptor (LXR)α. The pharmacological inhibition of PPARγ significantly (P<0.05) eliminated the Ang-(1-7)-mediated induction of ABCA1 ...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 6, 2002·Circulation·Peter LibbyAttilio Maseri
Mar 13, 2002·Circulation·Johann W AuerBernd Eber
Jan 3, 2004·Journal of Lipid Research·Jonathan D SmithMichael N Oda
Oct 31, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tomoko KanomeAkira Miyazaki
Jun 18, 2009·Molecular Cancer Therapeutics·Steven E TrasinoThomas T Y Wang
Oct 3, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Laurent Yvan-CharvetAlan R Tall
May 8, 2010·European Journal of Pharmacology·Gursev S DhaunsiIbrahim F Benter
May 2, 2012·Molecular and Cellular Endocrinology·Zsuzsanna S NagyLaszlo Nagy
Sep 6, 2012·Atherosclerosis·Yutang WangJonathan Golledge
Oct 4, 2012·Clinical and Experimental Pharmacology & Physiology·Hui-Yu YangZhi-Ming Yang
Oct 25, 2012·The Journal of Endocrinology·Robson A S SantosMichael Bader
Apr 5, 2013·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Erin G RosenbaughMatthew C Zimmerman
Apr 23, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Kyoung-jin MinTaeg Kyu Kwon
Jun 21, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Xiao-Hua YuChao-Ke Tang
Jul 3, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Hiroyuki KawahitoHiroaki Matsubara
Jul 28, 2013·Immunobiology·Ioana Madalina Fenyo, Anca Violeta Gafencu

❮ Previous
Next ❯

Citations

Jun 9, 2016·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Minakshi RanaManoj Kumar Barthwal
Jan 12, 2021·American Journal of Physiology. Renal Physiology·Jing LiuChun-Ming Jiang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.